Form 15-15D/A - Suspension of duty to report [Section 13 and 15(d)]: [Amend]
SEC Accession No. 0001641172-25-012799
Filing Date
2025-05-29
Accepted
2025-05-29 09:30:03
Documents
1
Effectiveness Date
2025-05-29

Document Format Files

Seq Description Document Type Size
1 15-15D/A form15-15da.htm 15-15D/A 20401
  Complete submission text file 0001641172-25-012799.txt   21411
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 15-15D/A | Act: 34 | File No.: 333-191725 | Film No.: 25998192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)